Teva Pharmaceutical Industries LTD Adr (TEVA) Shares Declined While Sandy Spring Bank Lowered Holding by $520,302; Ghp Investment Advisors Lowered Its Stake in West Pharmaceutical Svsc (WST) by $2.01 Million as Share Price Rose

January 14, 2018 - By Richard Conner

Sandy Spring Bank decreased its stake in Teva Pharmaceutical Industries Ltd Adr (TEVA) by 95.56% based on its latest 2017Q3 regulatory filing with the SEC. Sandy Spring Bank sold 30,606 shares as the company’s stock declined 15.11% while stock markets rallied. The institutional investor held 1,423 shares of the major pharmaceuticals company at the end of 2017Q3, valued at $25,000, down from 32,029 at the end of the previous reported quarter. Sandy Spring Bank who had been investing in Teva Pharmaceutical Industries Ltd Adr for a number of months, seems to be less bullish one the $22.42B market cap company. The stock increased 1.52% or $0.33 during the last trading session, reaching $22.07. About 40.56M shares traded or 52.13% up from the average. Teva Pharmaceutical Industries Limited (NYSE:TEVA) has declined 41.70% since January 14, 2017 and is downtrending. It has underperformed by 58.40% the S&P500.

Ghp Investment Advisors Inc decreased its stake in West Pharmaceutical Svsc Inc (WST) by 51.35% based on its latest 2017Q3 regulatory filing with the SEC. Ghp Investment Advisors Inc sold 20,937 shares as the company’s stock rose 14.65% with the market. The institutional investor held 19,835 shares of the basic industries company at the end of 2017Q3, valued at $1.91 million, down from 40,772 at the end of the previous reported quarter. Ghp Investment Advisors Inc who had been investing in West Pharmaceutical Svsc Inc for a number of months, seems to be less bullish one the $7.26 billion market cap company. The stock decreased 1.36% or $1.35 during the last trading session, reaching $97.74. About 414,340 shares traded or 16.48% up from the average. West Pharmaceutical Services, Inc. (NYSE:WST) has risen 33.75% since January 14, 2017 and is uptrending. It has outperformed by 17.05% the S&P500.

Ghp Investment Advisors Inc, which manages about $821.66M and $659.31 million US Long portfolio, upped its stake in Powershares Etf Tr Ii (IDLV) by 37,295 shares to 343,032 shares, valued at $11.38M in 2017Q3, according to the filing. It also increased its holding in Ishares U S Etf Tr by 49,569 shares in the quarter, for a total of 412,074 shares, and has risen its stake in Littelfuse Inc (NASDAQ:LFUS).

Among 5 analysts covering West Pharmaceutical Services (NYSE:WST), 3 have Buy rating, 0 Sell and 2 Hold. Therefore 60% are positive. West Pharmaceutical Services had 13 analyst reports since August 4, 2015 according to SRatingsIntel. The firm has “Outperform” rating given on Tuesday, March 22 by Wells Fargo. The stock of West Pharmaceutical Services, Inc. (NYSE:WST) earned “Outperform” rating by Wells Fargo on Friday, October 27. The rating was upgraded by Wells Fargo to “Outperform” on Friday, October 28. As per Thursday, June 29, the company rating was maintained by Jefferies. The stock has “Market Perform” rating by Wells Fargo on Wednesday, September 21. Zacks downgraded the shares of WST in report on Tuesday, August 4 to “Hold” rating. Janney Capital initiated the shares of WST in report on Friday, January 8 with “Buy” rating. The company was upgraded on Friday, September 15 by Jefferies. The stock has “Hold” rating by Jefferies on Monday, September 11. The rating was downgraded by Bank of America on Tuesday, October 17 to “Hold”.

Since December 8, 2017, it had 0 insider purchases, and 1 sale for $2.08 million activity.

Investors sentiment decreased to 1.33 in Q3 2017. Its down 0.28, from 1.61 in 2017Q2. It dropped, as 31 investors sold WST shares while 76 reduced holdings. 42 funds opened positions while 100 raised stakes. 68.09 million shares or 1.49% more from 67.09 million shares in 2017Q2 were reported. Credit Suisse Ag holds 0.01% or 92,764 shares in its portfolio. 3,987 are owned by Eqis Management. Cap One Association has 0.09% invested in West Pharmaceutical Services, Inc. (NYSE:WST) for 13,717 shares. Rmb Mngmt Ltd, a Illinois-based fund reported 138,987 shares. Tompkins Fincl Corporation holds 0.01% or 336 shares in its portfolio. Nationwide Fund Advsrs, a Pennsylvania-based fund reported 138,549 shares. Principal Incorporated holds 0.03% of its portfolio in West Pharmaceutical Services, Inc. (NYSE:WST) for 309,889 shares. Strs Ohio accumulated 143,000 shares. Credit Agricole S A reported 0.01% in West Pharmaceutical Services, Inc. (NYSE:WST). Sit Assocs owns 0.02% invested in West Pharmaceutical Services, Inc. (NYSE:WST) for 9,600 shares. Td Asset Mgmt holds 0.02% or 106,275 shares in its portfolio. Westfield Cap Mgmt Com Lp stated it has 0% of its portfolio in West Pharmaceutical Services, Inc. (NYSE:WST). Sumitomo Mitsui Asset Mngmt Communication Limited owns 0.02% invested in West Pharmaceutical Services, Inc. (NYSE:WST) for 14,310 shares. Moreover, Private Advisor Gru Ltd Co has 0% invested in West Pharmaceutical Services, Inc. (NYSE:WST). Blackrock accumulated 5.89M shares.

Analysts await West Pharmaceutical Services, Inc. (NYSE:WST) to report earnings on February, 15. They expect $0.61 EPS, up 12.96% or $0.07 from last year’s $0.54 per share. WST’s profit will be $45.29M for 40.06 P/E if the $0.61 EPS becomes a reality. After $0.67 actual EPS reported by West Pharmaceutical Services, Inc. for the previous quarter, Wall Street now forecasts -8.96% negative EPS growth.

Among 33 analysts covering Teva Pharma (NYSE:TEVA), 9 have Buy rating, 7 Sell and 17 Hold. Therefore 27% are positive. Teva Pharma had 127 analyst reports since July 21, 2015 according to SRatingsIntel. The rating was maintained by Jefferies with “Buy” on Thursday, July 14. The firm has “Buy” rating by Goldman Sachs given on Monday, November 23. The stock of Teva Pharmaceutical Industries Limited (NYSE:TEVA) has “Neutral” rating given on Friday, August 4 by Credit Suisse. Mizuho downgraded Teva Pharmaceutical Industries Limited (NYSE:TEVA) on Friday, February 10 to “Neutral” rating. The firm has “Buy” rating given on Tuesday, June 27 by Oppenheimer. As per Wednesday, October 4, the company rating was maintained by Barclays Capital. On Friday, January 6 the stock rating was downgraded by Maxim Group to “Hold”. The firm has “Outperform” rating given on Friday, February 19 by Wells Fargo. On Friday, December 4 the stock rating was upgraded by Guggenheim to “Buy”. The rating was maintained by Mizuho on Thursday, October 26 with “Hold”.

Sandy Spring Bank, which manages about $1.04 billion US Long portfolio, upped its stake in Nvidia Corp (NASDAQ:NVDA) by 2,135 shares to 5,200 shares, valued at $930,000 in 2017Q3, according to the filing. It also increased its holding in Walt Disney Company (NYSE:DIS) by 3,096 shares in the quarter, for a total of 124,916 shares, and has risen its stake in Ishares S&P Midcap 400 Index (IJH).

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>